Chargement en cours...
The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing
OBJECTIVE: In the U.S., genetic testing for maturity-onset diabetes of the young (MODY) is frequently delayed because of difficulty with insurance coverage. Understanding the economic implications of clinical genetic testing is imperative to advance precision medicine for diabetes. The objective of...
Enregistré dans:
| Publié dans: | Diabetes Care |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Diabetes Association
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6868460/ https://ncbi.nlm.nih.gov/pubmed/31558549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-0486 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|